187 related articles for article (PubMed ID: 921888)
1. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Stephens TC; Peacock JH
Br J Cancer; 1977 Sep; 36(3):313-21. PubMed ID: 921888
[TBL] [Abstract][Full Text] [Related]
2. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
Stephens TC; Peacock JH
Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
[TBL] [Abstract][Full Text] [Related]
3. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
Hill RP; Stanley JA
Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
Zeller WJ; Berger M
Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
[TBL] [Abstract][Full Text] [Related]
5. Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapy.
Mulder JH; Edelstein MB; Lelieveld P; van Putten IM
Eur J Cancer (1965); 1978 May; 14(5):537-42. PubMed ID: 648568
[No Abstract] [Full Text] [Related]
6. Response of two mouse tumours to hyperthermia with CCNU or melphalan.
Joiner MC; Steel GG; Stephens TC
Br J Cancer; 1982 Jan; 45(1):17-26. PubMed ID: 7059461
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma.
Laurent G; Atassi G; Hildebrand J
Cancer Res; 1976 Nov; 36(11 Pt 1):4069-73. PubMed ID: 975049
[TBL] [Abstract][Full Text] [Related]
8. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
9. Effects of nandrolone decanoate on the toxicity and anti-tumour action of CCNU and FU in murine tumours.
Bibby MC; Double JA; Mughal MA
Br J Cancer; 1981 Oct; 44(4):572-7. PubMed ID: 7295514
[TBL] [Abstract][Full Text] [Related]
10. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
11. Experiments on the chemotheraphy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
Waldbaur H; Kuschnir H; Engelmann U; Schmidt H; Schmack B
Acta Neurochir (Wien); 1978; 42(1-2):103-8. PubMed ID: 696438
[TBL] [Abstract][Full Text] [Related]
12. Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation.
Li XH; Paulus G; Atassi G; Buyssens N
Am J Pathol; 1984 Jun; 115(3):403-11. PubMed ID: 6731586
[TBL] [Abstract][Full Text] [Related]
13. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
Stephens TC; Adams K; Peacock JH
Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of combination chemotherapy by nitroheterocyclics.
Siemann DW; Allalunis-Turner MJ
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
[TBL] [Abstract][Full Text] [Related]
15. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
Muller PJ; Tator CH; Bloom ML
Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
[TBL] [Abstract][Full Text] [Related]
17. Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis.
Shih WW; Baumhefner RW; Tourtellotte WW; Haskell CM; Korn EL; Fahey JL
Clin Exp Immunol; 1983 Jul; 53(1):122-32. PubMed ID: 6603303
[TBL] [Abstract][Full Text] [Related]
18. Nitrosourea combination chemotherapy: 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (methyl-CCNU) and cyclophosphamide.
Lokich JJ; Skarin AT
Oncology; 1975; 32(3-4):169-74. PubMed ID: 768852
[TBL] [Abstract][Full Text] [Related]
19. The effect of amphotericin B on the survival of brain-tumor-bearing mice treated with CCNU.
Muller PJ; Tator CH
J Neurosurg; 1978 Oct; 49(4):579-88. PubMed ID: 690687
[TBL] [Abstract][Full Text] [Related]
20. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
Siemann DW; Morrissey S; Wolf K
Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
